PuSH - Publikationsserver des Helmholtz Zentrums München

Mitochondrial regulation of the 26S proteasome.

Cell Rep. 32:108059 (2020)
Verlagsversion Forschungsdaten DOI
Open Access Gold
Creative Commons Lizenzvertrag
The proteasome is the main proteolytic system for targeted protein degradation in the cell and is fine-tuned according to cellular needs. Here, we demonstrate that mitochondrial dysfunction and concomitant metabolic reprogramming of the tricarboxylic acid (TCA) cycle reduce the assembly and activity of the 26S proteasome. Both mitochondrial mutations in respiratory complex I and treatment with the anti-diabetic drug metformin impair 26S proteasome activity. Defective 26S assembly is reversible and can be overcome by supplementation of aspartate or pyruvate. This metabolic regulation of 26S activity involves specific regulation of proteasome assembly factors via the mTORC1 pathway. Of note, reducing 26S activity by metformin confers increased resistance toward the proteasome inhibitor bortezomib, which is reversible upon pyruvate supplementation. Our study uncovers unexpected consequences of defective mitochondrial metabolism for proteasomal protein degradation in the cell, which has important pathophysiological and therapeutic implications.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.109
1.707
11
15
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter 26s Proteasome ; Aspartate ; Metabolic Reprogramming ; Metformin ; Mitochondria ; Proteasome Assembly Factors ; Proteasome Inhibitor Resistance ; Pyruvate ; Respiratory Complex I ; Rpn6 ; Tca; Complex I Deficiency; Protein-synthesis; Mutations Cause; Cultured-cells; Degradation; Phosphorylation; Diseases; Subunits; Pathway; System
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 2211-1247
e-ISSN 2211-1247
Zeitschrift Cell Reports
Quellenangaben Band: 32, Heft: 8, Seiten: , Artikelnummer: 108059 Supplement: ,
Verlag Cell Press
Verlagsort 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Begutachtungsstatus Peer reviewed
POF Topic(s) 30202 - Environmental Health
30203 - Molecular Targets and Therapies
80000 - German Center for Lung Research
30201 - Metabolic Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Lung Research
Enabling and Novel Technologies
Genetics and Epidemiology
Helmholtz Diabetes Center
PSP-Element(e) G-501600-004
G-505200-001
G-501800-810
G-505600-003
G-500700-001
G-502295-001
G-503292-001
G-505700-001
A-630700-001
G-505200-003
Scopus ID 85089800991
Erfassungsdatum 2020-09-21